Story perspectives

Appeals Court to Hear Tylenol Autism Claims Amid Controversy

11/17/2025

32 4

Summary

Story summary

A U.S. appeals court will hear families' arguments to revive lawsuits against Kenvue over Tylenol and autism claims.
U.S. President Donald Trump expressed support for these claims at a press conference.
A Texas judge allowed Kenvue to pay a $398 million dividend, rejecting efforts to block it, a move potentially affecting Kimberly-Clark's planned acquisition.
The FDA is considering new labeling for Tylenol as medical societies dispute any autism link.

1 of 1

Story summary

A U.S. appeals court will hear families' arguments to revive lawsuits against Kenvue over Tylenol and autism claims.
U.S. President Donald Trump expressed support for these claims at a press conference.
A Texas judge allowed Kenvue to pay a $398 million dividend, rejecting efforts to block it, a move potentially affecting Kimberly-Clark's planned acquisition.
The FDA is considering new labeling for Tylenol as medical societies dispute any autism link.